ENOVANT

WIPO WIPO 2018

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ENOVANT wurde als Wortmarke am 11.09.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 27. November 2020

Markenform Wortmarke
Aktenzeichen 1454917
Registernummer 720508
Länder Europäische Gemeinschaft Großbritannien Japan Südkorea Singapur
Basismarke CH Nr. 720508, 13. März 2018
Anmeldedatum 11. September 2018
Ablaufdatum 11. September 2028

Markeninhaber

Viaduktstrasse 8
4051 Basel
CH

Markenvertreter

Fross Zelnick Lehrman & Zissu, P.C. 4 Times Square, 17th Floor US

Waren und Dienstleistungen

09 Calculating machines, data processing equipment, computer equipment; computer software; computer software for providing, analyzing and generating reports; computer software for data processing; electronic apparatus, electronic devices, software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of public health, healthcare, pharmaceutical and biomedical research and development, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, and the provision of medical and healthcare services; downloadable computer software featuring computer databases containing information in the pharmaceutical and medical field; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and for accessing and providing news information of general interest; computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information
35 Business consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; professional business analysis and consultancy and statistical analysis in the fields of public health, healthcare, biomedicine, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare from an on-line database; arranging of commercial and business contacts within the scientific research and medical communities to achieve advances in the field of healthcare; business networking services within the scientific research and medical communities to achieve advances in the field of healthcare; compilation of data, analysis of business data and professional business analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; compilation of data, analysis of business data and professional business analysis for medical, public health and healthcare purposes; providing reimbursement comparative evaluation information and other market intelligence to healthcare organizations; collecting insurance claims data and business analysis of insurance claims data from health and health care organizations for commercial purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for business purposes; compiling data for research and analysis purposes in the fields of public health and healthcare, pharmaceuticals, biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines
36 Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, financial analysis of statistics and data as well as compilation of statistics; financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; research related to financial instruments
42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; clinical trials; pharmaceutical and biomedical research services, namely post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; epidemiological research services; pharmaco-epidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of public health and healthcare, pharmaceuticals, biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research and pharmaco-epidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmaco-epidemiological research and data from clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; providing scientific research information in the fields of public health and healthcare, biomedicine, pharmaceuticals, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; providing temporary use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
24. September 2020 2020/40 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
21. Mai 2020 2020/22 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
07. Mai 2020 2020/19 Gaz JP Ablehnung
09. April 2020 2020/22 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
01. Dezember 2019 2019/49 Gaz KR Ablehnung
19. August 2019 2019/34 Gaz EM Ablehnung
29. Mai 2019 2019/22 Gaz GB Ablehnung
22. Mai 2019 2019/22 Gaz SG Ablehnung
11. September 2018 2019/9 Gaz CH Eintragung

ID: 141454917